Nielsen C H, Matthiesen S H, Lyng I, Leslie R G
Department of Medical Microbiology, Odense University, Denmark.
Immunology. 1997 Jan;90(1):129-37. doi: 10.1046/j.1365-2567.1997.00138.x.
Erythrocytes (E) express complement receptor, type 1 (CR1, CD35), by which they bind opsonized immune complexes (IC) in competition with leucocytes expressing higher numbers of CR1 as well as other complement- and Fc-receptors. This may prevent inappropriate activation of phagocytic cells. We examined the distribution on whole blood cells of preformed tetanus toxoid (TT)/human anti-TT IC, opsonized in situ in 80% autologous serum. Binding to E occurred rapidly and reflected the kinetics of C3-fragment incorporation into the IC. Among eight donors, expressing 180-361 CR1 per E. > 90% of the cell-bound IC were associated with E from 1 to 5 min of incubation, decreasing to 12 +/- 13% after 40 min. Upon comparison of the IC-binding to leucocytes in whole blood with that of isolated leucocytes we found that E, despite their extensive early complex uptake, only reduced the IC-deposition on polymorphonuclear leucocytes (PMN) by 61 +/- 26% after 30 seconds of incubation and 47 +/- 14% after 5 min. During the subsequent 10 min, this buffering capacity of E was essentially abolished E restricted the initial IC-binding to B cells by 73 +/- 19%, but from 3 min of incubation the presence of E promoted, in a CR1-dependent manner, a progressive uptake via CR2 by the B cells. CR1 was the dominant receptor in the early IC-uptake by B cells as well as PMN and monocytes, since CR1-blockade inhibited the initial IC-uptake by these populations in a preparation of isolated leucocytes suspended in serum by > or = 84% after 30 seconds of incubation. We conclude, that E exert a substantial buffering effect on the IC-deposition on PMN, monocytes and B cells, while CR1 is the dominant receptor in the uptake by these cells. However, this effect is short-lived and less than expected from the proportion of IC bound to E. Moreover, E are efficient processors of IC-attached C3b/iC3b fragments to C3dg as indicated by a pronounced enhancement by E of IC-uptake via CR2 on B cells. We propose that this mechanism may play a role in preventing phagocyte activation via CR3.
红细胞(E)表达1型补体受体(CR1,CD35),通过该受体它们与调理素化的免疫复合物(IC)结合,与表达更多CR1以及其他补体和Fc受体的白细胞竞争。这可能会阻止吞噬细胞的不适当激活。我们检测了预先形成的破伤风类毒素(TT)/人抗TT免疫复合物在80%自体血清中原位调理后的全血细胞分布情况。与红细胞的结合迅速,并反映了C3片段掺入免疫复合物的动力学。在8名供体中,每个红细胞表达180 - 361个CR1,在孵育1至5分钟时,>90%与细胞结合的免疫复合物与红细胞相关,40分钟后降至12±13%。将全血中免疫复合物与白细胞的结合情况与分离的白细胞进行比较时,我们发现红细胞尽管在早期大量摄取复合物,但在孵育30秒后仅使多形核白细胞(PMN)上的免疫复合物沉积减少61±26%,5分钟后减少47±14%。在随后的10分钟内,红细胞的这种缓冲能力基本消失。红细胞将最初与B细胞的免疫复合物结合限制了73±19%,但从孵育3分钟起,红细胞的存在以CR1依赖的方式促进B细胞通过CR2进行逐渐摄取。CR1是B细胞以及PMN和单核细胞早期摄取免疫复合物的主要受体,因为在孵育30秒后,在悬浮于血清中的分离白细胞制剂中,CR1阻断抑制了这些细胞群体最初的免疫复合物摄取≥84%。我们得出结论,红细胞对PMN、单核细胞和B细胞上免疫复合物的沉积具有显著的缓冲作用,而CR1是这些细胞摄取免疫复合物的主要受体。然而,这种作用是短暂的,且低于根据与红细胞结合的免疫复合物比例所预期的效果。此外,红细胞是将免疫复合物附着的C3b/iC3b片段有效加工为C3dg的细胞,这表现为红细胞显著增强了B细胞通过CR2摄取免疫复合物的能力。我们提出这种机制可能在通过CR3防止吞噬细胞激活中发挥作用。